In patients with HCV-related hepatocellular carcinoma (HCC), only serum IP-10 level, but no other HCC-associated growth factors, was significantly declined after HCV clearance, suggesting no promotion of HCC using DAA treatment for patients with HCV-related HCC (19). Here, CXCL10 is linked to hepatocellular carcinoma.